Blister
Cicatricial Pemphigoid
search
Cicatricial Pemphigoid
, Scarring Pemphigoid, Mucosal Pemphigoid
See Also
Pemphigoid
Bullous Disease
Epidemiology
Incidence
(rare): 1 in 12,000 to 20,000
Ages affected: 60 to 80 years
Gender predominence: Women by ratio of 2:1
Pathophysiology
Autoimmune
Bullous Condition
Associated conditions
Stevens-Johnson Syndrome
Medications
Topical
Glaucoma
medications
Practolol
Clonidine
Signs
Blister
ing of mucus membranes
Blister
ruptures within hours of formation
Painful erosion
Most erosions heal without scarring
Most common sites of involvement
Oral Mucosa
(most often buccal and palatal mucosa)
Results in erosive
Gingivitis
Conjunctiva
(usually bilateral)
Results in chronic
Conjunctivitis
and scarring
Other sites of involvement
Skin (usually non-scarring)
Scalp (Cicatricial
Alopecia
)
Pharynx and
Larynx
External genitalia
Nasal mucosa
Anus
Esophagus
Labs
Histology
Subepidermal bulla
Perivascular inflammatory cell infiltrates
Fibrosis distinguishes from
Bullous Pemphigoid
Immunofluorescence with IgG, C3, IgA deposits
Forms linear band at Basement Membrane Zone
Differential Diagnosis
See Autoimmune
Bullous Condition
Bullous Pemphigoid
Epidermolysis Bullosa Acquisita
(EBA)
Linear IgA Bullous Dermatosis
(LABD)
Systemic Lupus Erythematosus
Pseudopemphigoid
Pemphigus
Management
Early aggressive treatment
First-Line:
Prednisone
0.5 to 0.75 mg/kg/day x6 months
Ocular Involvement:
Azathioprine
or
Cyclophosphamide
Skin Involvement:
Topical Corticosteroid
s
Oral Involvement
Dapsone
Corticosteroid
gel
Dexamethasone
mouthwash (Roxane)
Complications
Ocular Lesions may result in blindness
Laryngeal stricture
Esophageal Stricture
Supraglottic Stenosis
References
Bickle (2002) Am Fam Physician 65(9):1861-70 [PubMed]
Cotell (2000) Am J Emerg Med 18(3):288-99 [PubMed]
Fleming (2000) J Am Acad Dermatol 43(4):571-91 [PubMed]
Type your search phrase here